A Study of Baricitinib and Simvastatin in Healthy Participants
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine the effects of baricitinib on the time it takes
to remove simvastatin from the body and to look at how well-tolerated and safe baricitinib is
when given alone and in combination with simvastatin. Side effects will be documented. The
study will last approximately 7 days from the first dose to the end of the study (not
including screening or follow-up).